OraSure Technologies Announces Inclusion in the Russell 3000 Index

BETHLEHEM, Pa., Jun 20, 2001 (BW HealthWire) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that its stock has recently been included in the Russell 3000(R) Index.

This index is compiled by the Frank Russell Company and is a ranking of the 3,000 largest U.S. stocks by market capitalization. At the close of trading on May 31, 2001, OraSure's market capitalization was approximately $413.9 million.

"We're pleased to be included in this widely recognized market index," said Robert D. Thompson, Chief Executive Officer of OraSure Technologies. "This is solid evidence that we are being recognized by investors as we continue to implement our strategies and grow our revenues."

OraSure Technologies (Nasdaq/NM:OSUR)

Investment Data
-------------------------------------------------------               
52-Week Range                            $5.56 - $15.93

Market Capitalization                    $413.9 million

Institutional Ownership                  30%

Shares Outstanding                       36.6 million

Float                                    26.0 million

FY 2000 Revenue                          $28.8 million

    About OraSure Technologies

OraSure Technologies, Inc. develops, manufactures and markets medical devices and diagnostic products for use by public- and private-sector clients, clinical laboratories, physicians' offices and workplace testing. OraSure Technologies is the leading supplier of oral fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the company supplies oral fluid testing solutions for drugs-of-abuse testing. For more information on the company, please go to www.orasure.com.

CONTACT:          OraSure Technologies
                  Mr. Rich Hooper, 610/882-1820
                  investorinfo@orasure.com
                  www.orasure.com